The Bombay High Court took a firm stance against the Maharashtra FDA, rebuking its treatment of Cipla and five eateries. The court underscored that the FDA’s decisions compromised natural justice and displayed an inflexible approach. With the court’s direction, the FDA rescinded its suspension of the Mumbai Cricket Association restaurants and reinstated Cipla’s drug sale licence. The court called on the FDA to practice due diligence in its enforcement strategies.
